The cell cycle and apoptosis are quintessential regulatory components of NF-κB signaling in human cancer.12 Thus, we investigated whether alterations in these processes could explain the strikingly reduced tumor cell growth observed in RelB-deficient EEC cells. The gene discussed is NFKB1; the disease is cancer.